Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


FRIEDLI PETER Create: Alert

All | News | Filings
Date FiledTypeDescription
04/17/2019 4 FRIEDLI PETER (Director) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns: Disposed/sold 10,204,404 shares @ $19, valued at $193.9M
Disposed/sold 4,103,301 shares @ $19, valued at $78M
Disposed/sold 500,000 shares @ $19, valued at $9.5M
Disposed/sold 2,750 shares @ $19, valued at $52.3k
07/25/2018 SC 13D/A FRIEDLI PETER reports a 42.9% stake in Osiris Therapeutics, Inc.
02/07/2014 4 FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns: Granted 10,000 shares @ $14.93, valued at $149.3k
01/21/2014 4 FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
08/16/2013 4 FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 432,390 shares @ $25.44, valued at $11M
Exercised 1,000,000 warrants @ $11, valued at $11M
02/13/2013 4 FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns: Granted 10,000 shares @ $7.73, valued at $77.3k
12/28/2012 SC 13D/A FRIEDLI PETER reports a 44.9% stake in Osiris Therapeutics, Inc.
12/10/2012 4 FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns: Sold 50,000 shares @ $9.52, valued at $476k
11/16/2012 4 FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns: Sold 625 shares @ $9.34, valued at $5.8k
03/27/2012 4 FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns: Granted 10,000 shares @ $5.08, valued at $50.8k
12/07/2011 4 FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns: Gifted 500,000 shares @ $4.87, valued at $2.4M
02/16/2011 4 FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.
Txns: Granted 10,000 shares @ $7.13, valued at $71.3k
02/25/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
09/25/2008 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/31/2007 SC 13D/A FRIEDLI PETER reports a 48.4% stake in Osiris Therapeutics, Inc.
09/27/2007 SC 13D/A Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
06/13/2007 SC 13D/A SEC Filing in the EDGAR database
12/20/2006 SC 13D SEC Filing in the EDGAR database
11/02/2005 SC 13G/A FRIEDLI PETER reports a 0% stake in
10/18/2005 SC 13G/A FRIEDLI PETER reports a 0% stake in
09/27/2005 SC 13G/A FRIEDLI PETER reports a 0% stake in
04/04/2005 SC 13D/A FRIEDLI PETER reports a 0% stake in
04/07/2003 SC 13D/A FRIEDLI PETER reports a 0% stake in
03/05/2003 SC 13G/A FRIEDLI PETER reports a 0% stake in
02/06/2003 SC 13D FRIEDLI PETER reports a 0% stake in
04/29/2002 SC 13G/A FRIEDLI PETER reports a 0% stake in
02/14/2002 SC 13G/A FRIEDLI PETER reports a 0% stake in
10/26/2001 SC 13G/A FRIEDLI PETER reports a 0% stake in
05/21/2001 SC 13G FRIEDLI PETER reports a 0% stake in
02/14/2001 SC 13G FRIEDLI PETER reports a 0% stake in
02/08/2001 SC 13D FRIEDLI PETER reports a 0% stake in
02/13/1997 SC 13D/A FRIEDLI PETER reports a 0% stake in
11/08/1996 DEFC14A Form DEFC14A - Definitive proxy statement, contested solicitations:
10/22/1996 SC 13D FRIEDLI PETER reports a 0% stake in

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy